- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Trastuzumab
Total 1149 results
-
Novartis PharmaceuticalsCompletedMetastases, BrainSpain, Hungary, Poland, Germany, Italy, Russian Federation, Sweden, United Kingdom, Thailand, United States, Belgium, France, Greece, Denmark
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast Carcinoma | Locally Advanced Breast Carcinoma | Breast Inflammatory CarcinomaUnited States
-
Institut CurieSeagen Inc.RecruitingHER2-positive Breast CancerFrance
-
Henan Cancer HospitalUnknown
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLung CancerUnited States, South Africa, Puerto Rico
-
Iambic Therapeutics, IncRecruiting
-
Ottawa Hospital Research InstituteRecruiting
-
AC Camargo Cancer CenterTerminatedTrastuzumab to Patients With Advanced Gastric Cancer With HER2 Positive Expression in CTC (GASTHER2)Gastric Cancer Stage IVBrazil
-
Shanghai Henlius BiotechCompleted
-
Novartis PharmaceuticalsCompletedAdvanced HER2-positive Breast CancerFrance, Italy, Germany, Singapore, Sweden, Spain, United Kingdom, United States
-
Medical University of ViennaUnknownMetastatic Breast CancerAustria
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingHER2-positive Breast Cancer
-
Adrienne G. WaksGilead SciencesRecruitingBreast Cancer Female | Breast Cancer Metastatic | Her 2 Positive Breast CancerUnited States
-
Henan Cancer HospitalActive, not recruiting
-
NSABP Foundation IncWashington University School of Medicine; Breast Cancer Research FoundationActive, not recruiting
-
Hoffmann-La RocheCompletedBreast CancerUnited Kingdom, Spain, Australia, Sweden
-
National Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Henan Cancer HospitalCompletedHER2 Positive Breast CancerChina
-
Hoffmann-La RocheCompletedBreast CancerHungary, Italy, Spain, France, United Kingdom, Belgium, Germany, Portugal, Poland, Canada, Bulgaria, Mexico
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Hoffmann-La RocheRecruitingLocally Advanced or Metastatic Breast CancerFrance, Belgium, United States, Korea, Republic of, Taiwan, China, Italy, Argentina, Jordan, Mexico, Brazil, Germany, Portugal, Thailand, Turkey, United Kingdom, Kenya, Spain, Hungary, Colombia, India, Oman, Poland, Uganda, United Arab...
-
National Cancer Institute (NCI)WithdrawnBreast Cancer | Breast Neoplasms | Lung Neoplasms | Lung Cancer
-
Shanghai Changzheng HospitalUnknown
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Genentech, Inc.CompletedHead and Neck CancerUnited States
-
Fudan UniversityRecruiting
-
City of Hope Medical CenterActive, not recruitingBreast Cancer | Stage IV Breast CancerUnited States
-
Dana-Farber Cancer InstituteActive, not recruiting
-
Hoffmann-La RocheCompleted
-
University Medical Center GroningenAmsterdam UMC, location VUmc; University Medical Center NijmegenActive, not recruitingMetastatic Breast CancerNetherlands
-
National Cancer Institute, NaplesActive, not recruitingMetastatic Breast CancerItaly
-
Yonsei UniversityActive, not recruitingRecurrent/Metastatic Gastric CancerKorea, Republic of
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedBreast Cancer | Metastatic Breast Cancer | Progressive Breast CancerUnited States
-
Hoffmann-La RocheCompleted
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI)Completed
-
Canadian Cancer Trials GroupAstraZenecaCompletedMetastatic Breast CancerCanada
-
Memorial Sloan Kettering Cancer CenterTerminatedGastric Cancer | Esophageal Cancer | Esophageal Neoplasms | Gastroesophageal Junction Cancer | Gastric Tumor | Gastroesophageal Junction Adenocarcinoma | GastroEsophageal Cancer | Esophageal Tumor | Esophagogastric Tumors | Gastroesophageal Junction TumorUnited States
-
Shandong Cancer Hospital and InstituteUnknownMetastatic Breast Cancer | HER2-positive Breast Cancer
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerChina, Korea, Republic of, United States, Germany, Italy, Poland, Belgium, Mexico, Turkey, Spain, France, Canada, Taiwan, Brazil, Austria, Hong Kong, India, Japan, Netherlands, Denmark
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZeneca UK LimitedRecruitingBreast Cancer | Non-small Cell Lung CarcinomaUnited States, Spain, United Kingdom, France
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States, Canada
-
SanofiCompletedBreast Cancer | Breast NeoplasmsUnited States, Spain
-
The Netherlands Cancer InstituteCompletedBreast Cancer | HER2 PositiveNetherlands
-
Danish Breast Cancer Cooperative GroupSanofi; Hoffmann-La RocheUnknown
-
Byondis B.V.CompletedSolid TumorUnited Kingdom, Belgium, Netherlands
-
National Cancer Institute (NCI)TerminatedBreast Cancer | Brain Cancer | Brain MetastasisUnited States
-
Daiichi Sankyo, Inc.Bristol-Myers Squibb; AstraZenecaActive, not recruitingBreast Cancer | Urothelial CarcinomaUnited States, Spain, Italy, Belgium, France, Germany, United Kingdom
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingFirst-line Treatment | HER2-positive Metastatic Breast CancerChina
-
Wuhan Union Hospital, ChinaRecruitingBreast Cancer | NeoadjuvantChina